实验研究
ENGLISH ABSTRACT
TRPC3对OIR小鼠视网膜和人视网膜血管内皮细胞生物学行为的调控作用
张越
刘晓静
甄宇涵
姚瑶
邵斌
徐嫚鸿
王艳辉
刘志强
王伟
毛爱玲
张宝月
张铭连
陈志敏
作者及单位信息
·
DOI: 10.3760/cma.j.cn115989-20230606-00217
Regulatory effect of TRPC3 on the biological behavior of retina in OIR mice and human retinal endothelial cells
Zhang Yue
Liu Xiaojing
Zhen Yuhan
Yao Yao
Shao Bin
Xu Manhong
Wang Yanhui
Liu Zhiqiang
Wang Wei
Mao Ailing
Zhang Baoyue
Zhang Minglian
Chen Zhimin
Authors Info & Affiliations
Zhang Yue
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Liu Xiaojing
Department of Ophthalmology, Hebei Medical University, Shijiazhuang 050017, China
Zhen Yuhan
Department of Ophthalmology, Hebei Medical University, Shijiazhuang 050017, China
Yao Yao
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Shao Bin
Department of Ophthalmology, Hebei Medical University, Shijiazhuang 050017, China
Xu Manhong
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300020, China
Wang Yanhui
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Liu Zhiqiang
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Wang Wei
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Mao Ailing
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Zhang Baoyue
Department of Ophthalmology, Hebei Medical University, Shijiazhuang 050017, China
Zhang Minglian
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
Chen Zhimin
Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, Xingtai 054001, China
·
DOI: 10.3760/cma.j.cn115989-20230606-00217
220
37
0
0
1
0
PDF下载
APP内阅读
摘要

目的探讨瞬时受体电位阳离子通道亚家族C成员3(TRPC3)对氧诱导视网膜病变(OIR)小鼠视网膜和人视网膜血管内皮细胞(HREC)生物学行为的调控作用。

方法选取健康SPF级7日龄C57BL/6小鼠32只,采用随机数字表法分为对照组和OIR组,每组16只,其中对照组不做特殊处理,OIR组小鼠诱导OIR模型。出生后第17天(PN17)采用视网膜铺片免疫荧光染色验证模型构建是否成功。将体外培养HREC分为正常对照组、转染试剂组和si-TRPC3组,其中正常对照组不做特殊处理,转染试剂组和si-TRPC3组分别采用转染试剂和转染试剂+si-TRPC3转染。采用实时荧光定量PCR法检测TRPC3 mRNA相对表达量;采用Western blot法检测TRPC3、转录因子NF-E2相关因子(Nrf2)和超氧化物歧化酶(SOD)蛋白相对表达量。另将HREC分为正常对照组、血管内皮生长因子(VEGF)组、si-TRPC3组和Pyr3(TRPC3通道抑制剂)组,分别用完全培养基、含有20 ng/ml VEGF重组蛋白的培养基、含有20 ng/ml VEGF重组蛋白的培养基(si-TRPC3转染72 h)和含有20 ng/ml VEGF重组蛋白+1 μmol/L Pyr3的培养基培养48 h,采用细胞计数试剂盒8(CCK-8)检测HREC增生能力;分别采用细胞划痕实验和Transwell实验检测细胞横向和纵向迁移能力。

结果PN17时OIR组小鼠视网膜出现病理性新生血管团簇强荧光染色。OIR组小鼠视网膜TRPC3 mRNA和蛋白相对表达量分别为2.057±0.244和1.517±0.290,明显高于对照组的0.983±0.033和0.874±0.052,差异均有统计学意义( t=6.165、3.094,均 P<0.05)。si-TRPC3组TRPC3 mRNA和蛋白相对表达量明显低于正常对照组和转染试剂组,Nrf2和SOD蛋白相对表达量明显高于正常对照组和转染试剂组,差异均有统计学意义(均 P<0.05)。CCK-8实验结果显示,VEGF组细胞吸光度( A)值明显高于正常对照组,si-TRPC3组和Pyr3组细胞 A值明显低于VEGF组,差异均有统计学意义(均 P<0.05)。细胞划痕实验结果显示,VEGF组细胞横向迁移率高于正常对照组,si-TRPC3组和Pyr3组细胞横向迁移率低于VEGF组,差异均有统计学意义(均 P<0.05)。Transwell实验结果显示,VEGF组染色细胞数明显多于正常对照组,si-TRPC3组和Pyr3组染色细胞数明显少于VEGF组,差异均有统计学意义(均 P<0.05)。

结论OIR模型小鼠视网膜中TRPC3表达水平升高,下调TRPC3可抑制HREC增生和迁移能力,其机制与Nrf2氧化应激通路激活有关。

视网膜疾病;氧化应激;瞬时受体电位阳离子通道亚家族C成员3;人视网膜血管内皮细胞
ABSTRACT

ObjectiveTo investigate the regulatory effect of transient receptor potential cation channel subfamily C member 3 (TRPC3) on the retina in oxygen-induced retinopathy (OIR) mice and biological behavior of human retinal vascular endothelial cells (HREC).

MethodsA total of 32 healthy SPF grade 7-day-old C57BL/6 mice were selected and randomly divided into a control group and an OIR group by the random number table method, with 16 mice in each group.The control group received no special treatment, and the OIR model was established in the OIR group.On postnatal day 17 (PN17), the success of the model establishment was verified by immunofluorescence staining of the retinal patch.The in vitro cultured HREC were divided into a normal control group, a transfection reagent group, and a si-TRPC3 group.The normal control group received no special treatment, while the transfection reagent group and the si-TRPC3 group were transfected with transfection reagent or transfection reagent + si-TRPC3.The relative expression of TRPC3 mRNA was detected by real-time quantitative fluorescence PCR.The relative expressions of TRPC3, transcription factor NF-E2 related factor (Nrf2), and superoxide dismutase (SOD) proteins were determined by Western blot.HREC were further divided into a normal control group, a vascular endothelial growth factor (VEGF) group, a si-TRPC3 group, and a Pyr3 (TRPC3 channel inhibitor) group, which were cultured in complete medium, medium containing 20 ng/ml VEGF recombinant protein, medium containing 20 ng/ml VEGF recombinant protein (si-TRPC3 transfection for 72 hours), and medium containing 20 ng/ml VEGF recombinant protein+ 1 μmol/L Pyr3 for 48 hours, respectively.The proliferation ability of HREC was detected using cell counting kit 8 (CCK-8). The horizontal and vertical migration ability of cells were detected by cell scratch assay and transwell assay, respectively.This study followed the 3R principles of animal welfare and was approved by the Ethics Committee of Hebei Eye Hospital (No.2023LW04).

ResultsPathological neovascular clusters with strong fluorescent staining appeared in the retina of OIR mice on PN17.The relative expressions of TRPC3 mRNA and protein in the retina of OIR mice were 2.057±0.244 and 1.517±0.290, respectively, significantly higher than 0.983±0.033 and 0.874±0.052 of control group ( t=6.165, 3.094; both at P<0.05). The relative expression levels of TRPC3 mRNA and protein were significantly lower, and the relative expression levels of Nrf2 and SOD proteins were higher in the si-TRPC3 group than in the normal control and transfection reagent groups, and the differences were statistically significant (all at P<0.05). The CCK-8 experiment results showed that the cell absorbance value was higher in the VEGF group than in the normal control group, and lower in the si-TRPC3 and Pyr3 groups than in the VEGF group, with statistically significant differences (all at P<0.05). The results of the cell scratch experiment showed that the lateral migration rate of VEGF group cells was higher than that of normal control group, while the lateral migration rate of si-TRPC3 group and Pyr3 group cells was lower than that of VEGF group, and the differences were statistically significant (all at P<0.05). The transwell experiment results showed that the number of stained cells in the VEGF group was higher than that in the normal control group, and the number of stained cells in the si-TRPC3 group and Pyr3 group was lower than that in the VEGF group, with statistically significant differences (all at P<0.05).

ConclusionsHypoxia induces increased TRPC3 expression in OIR mouse retina, and downregulation of TRPC3 inhibits HREC proliferation and migration.The mechanism is related to the activation of the Nrf2-related oxidative stress pathway.

Retinal diseases;Oxidative stress;TRPC3 cation channel;Human retinal vascular endothelial cells
Chen Zhimin, Email: mocdef.6ab21mzcyyky
引用本文

张越,刘晓静,甄宇涵,等. TRPC3对OIR小鼠视网膜和人视网膜血管内皮细胞生物学行为的调控作用[J]. 中华实验眼科杂志,2024,42(04):331-338.

DOI:10.3760/cma.j.cn115989-20230606-00217

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
视网膜新生血管可引起一系列威胁视力的常见疾病,如早产儿视网膜病变、增生性糖尿病视网膜病变、年龄相关性黄斑变性等 [ 1 , 2 , 3 ]。新生血管可在视网膜中迅速生长,并侵入玻璃体和神经视网膜层 [ 4 ]。新生血管需要大量细胞内活动实现,其中关键是内皮细胞被激活后的新生血管出芽、内皮细胞增生和细胞外基质成分的降解这一系列过程,最终导致内皮细胞的定向移动、血管形成和分化以及实现血管内血液灌注 [ 5 ]。生理条件下,促血管生成因子和抗血管生成因子保持动态平衡;病理条件下,促血管生长因子过表达导致新生血管性疾病发生和发展。激光光凝和抗血管内皮生长因子(vascular endothelial growth factor,VEGF)药物是目前治疗视网膜新生血管性疾病的主要方法,但存在一定的不良反应,且抗VEGF药物对部分患者无效 [ 6 ]。因此,寻找新的抗新生血管因子作为潜在治疗靶点成为治疗新生血管性疾病的目标。瞬时受体电位(transient receptor potential,TRP)通道超家族包含瞬时受体电位阳离子通道亚家族C(transient receptor potential cation channel subfamily C,TRPC)、TRPV、TRPM、TRPN、TRPA、TRPP和TRPML 7个亚家族 [ 7 ]。TRP通道家族通过向细胞内传递钠、钙离子,调控TRP通道活性,影响细胞膜兴奋性和细胞内钙离子水平,从而调节细胞功能 [ 8 ]。TRP通道家族已被证实具有促新生血管生成作用,并可调节细胞迁移和入侵 [ 9 , 10 ]。目前已知有7个TRPC通道。TRPC位于质膜,大部分以G蛋白偶联受体-磷脂酶C依赖性方式被激活。激活的TRPC允许钙离子和单价碱性阳离子进入细胞,导致细胞去极化和细胞内钙离子浓度升高 [ 11 ]。TRPC3功能的增强与心血管系统和大脑的病理活动有关,被确定为心肌成纤维细胞增生和分化的关键参与者 [ 12 ]。研究证实,TRPC3在高血压中可调控内皮祖细胞和成熟内皮细胞的功能 [ 13 ],然而TRPC3在视网膜内皮细胞中的作用研究甚少。本研究拟通过体内氧诱导视网膜病变(oxygen-induced retinopathy,OIR)模型和体外VEGF诱导人视网膜血管内皮细胞(human retinal vascular endothelial cells,HREC)增生模型,探讨TRPC3对视网膜血管形成和HREC生物学行为的调控作用。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Chang E , Rao P Adult retinopathy of prematurity:treatment implications,long term sequelae,and management[J]Curr Opin Ophthalmol 202132(5)∶489-493. DOI: 10.1097/ICU.0000000000000787 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Wong TY , Cheung CM , Larsen M et al. Diabetic retinopathy[J/OL]Nat Rev Dis Primers 2016216012[2023-10-20]https://pubmed.ncbi.nlm.nih.gov/27159554/. DOI: 10.1038/nrdp.2016.12 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Mettu PS , Allingham MJ , Cousins SW . Incomplete response to anti-VEGF therapy in neovascular AMD:exploring disease mechanisms and therapeutic opportunities[J/OL]Prog Retin Eye Res 202182100906[2023-10-20]https://pubmed.ncbi.nlm.nih.gov/33022379/. DOI: 10.1016/j.preteyeres.2020.100906 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Wong TY , Scott IU . Clinical practice.Retinal-vein occlusion[J]N Engl J Med 2010363(22)∶2135-2144. DOI: 10.1056/NEJMcp1003934 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Adams RH , Alitalo K Molecular regulation of angiogenesis and lymphangiogenesis[J]Nat Rev Mol Cell Biol 20078(6)∶464-478. DOI: 10.1038/nrm2183 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
张美霞关注湿性年龄相关性黄斑变性抗血管内皮生长因子治疗中的无应答病例[J]中华眼科杂志 201450(6)∶406-410. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.002 .
返回引文位置Google Scholar
百度学术
万方数据
Zhang MX . Attention to the non-responders to anti-VEGF treatment of wet age-related macular disease[J]Chin J Ophthalmol 201450(6)∶406-410. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.002 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[7]
Venkatachalam K , Montell C TRP channels[J]Annu Rev Biochem 200776387-417. DOI: 10.1146/annurev.biochem.75.103004.142819 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Moran MM . TRP channels as potential drug targets[J]Annu Rev Pharmacol Toxicol 201858309-330. DOI: 10.1146/annurev-pharmtox-010617-052832 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Yao X , Garland CJ . Recent developments in vascular endothelial cell transient receptor potential channels[J]Circ Res 200597(9)∶853-863. DOI: 10.1161/01.RES.0000187473.85419.3e .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Asghar MY , Törnquist K Transient receptor potential canonical (TRPC) channels as modulators of migration and invasion[J/OL]Int J Mol Sci 202021(5)∶1739[2023-10-21]https://pubmed.ncbi.nlm.nih.gov/32138386/. DOI: 10.3390/ijms21051739 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Chen X , Sooch G , Demaree IS et al. Transient receptor potential canonical (TRPC) channels:then and now[J/OL]Cells 20209(9)∶1983[2023-10-21]https://pubmed.ncbi.nlm.nih.gov/32872338/. DOI: 10.3390/cells9091983 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Tiapko O , Groschner K TRPC3 as a target of novel therapeutic interventions[J/OL]Cells 20187(7)∶83[2023-10-21]https://pubmed.ncbi.nlm.nih.gov/30037143/. DOI: 10.3390/cells7070083 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Poteser M , Graziani A , Eder P et al. Identification of a rare subset of adipose tissue-resident progenitor cells,which express CD133 and TRPC3 as a VEGF-regulated Ca 2+ entry channel [J]FEBS Lett 2008582(18)∶2696-2702. DOI: 10.1016/j.febslet.2008.06.049 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Connor KM , Krah NM , Dennison RJ et al. Quantification of oxygen-induced retinopathy in the mouse:a model of vessel loss,vessel regrowth and pathological angiogenesis[J]Nat Protoc 20094(11)∶1565-1573. DOI: 10.1038/nprot.2009.187 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
王嵘苏晓灵耿排力TRPC3参与缺氧诱导人脐静脉血管内皮细胞凋亡[J]陕西医学杂志 200938(12)∶1598-1603. DOI: 10.3969/j.issn.1000-7377.2009.12.010 .
返回引文位置Google Scholar
百度学术
万方数据
Wang R , Su XL , Geng PL et al. Effect of TRPC3 on apoptosis of HUVECs induced by hypoxia[J]Shaanxi Med J 200938(12)∶1598-1603. DOI: 10.3969/j.issn.1000-7377.2009.12.010 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[16]
Tiapko O , Groschner K TRPC3 as a target of novel therapeutic interventions[J/OL]Cells 20187(7)∶83[2023-10-22]https://pubmed.ncbi.nlm.nih.gov/30037143/. DOI: 10.3390/cells7070083 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Oda K , Umemura M , Nakakaji R et al. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration[J]J Physiol Sci 201767(4)∶497-505. DOI: 10.1007/s12576-016-0480-1 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Jiang HN , Zeng B , Zhang Y et al. Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer[J/OL]PLoS One 20138(6)∶e67637[2023-10-22]https://pubmed.ncbi.nlm.nih.gov/23840757/. DOI: 10.1371/journal.pone.0067637 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Kim JM , Heo K , Choi J et al. The histone variant MacroH2A regulates Ca 2+ influx through TRPC3 and TRPC6 channels [J/OL]Oncogenesis 20132(10)∶e77[2023-10-23]https://pubmed.ncbi.nlm.nih.gov/24165580/. DOI: 10.1038/oncsis.2013.40 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Yang SL , Cao Q , Zhou KC et al. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer[J]Oncogene 200928(10)∶1320-1328. DOI: 10.1038/onc.2008.475 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Aydar E , Yeo S , Djamgoz M et al. Abnormal expression,localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues:a potential target for breast cancer diagnosis and therapy[J/OL]Cancer Cell Int 2009923[2023-10-23]https://pubmed.ncbi.nlm.nih.gov/19689790/. DOI: 10.1186/1475-2867-9-23 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Smedlund K , Bah M , Vazquez G On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease[J]Cardiovasc Hematol Agents Med Chem 201210(3)∶265-274. DOI: 10.2174/187152512802651051 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Song HB , Jun HO , Kim JH et al. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization[J]Cell Calcium 201557(2)∶101-108. DOI: 10.1016/j.ceca.2015.01.002 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Antigny F , Girardin N , Frieden M Transient receptor potential canonical channels are required for in vitro endothelial tube formation [J]J Biol Chem 2012287(8)∶5917-5927. DOI: 10.1074/jbc.M111.295733 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Kiyonaka S , Kato K , Nishida M et al. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound[J]Proc Natl Acad Sci U S A 2009106(13)∶5400-5405. DOI: 10.1073/pnas.0808793106 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Lu M , Fang XX , Shi DD et al. A selective TRPC3 inhibitor Pyr3 attenuates myocardial ischemia/reperfusion injury in mice[J]Curr Med Sci 202040(6)∶1107-1113. DOI: 10.1007/s11596-020-2293-y .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Yang Q , Huang JH , Underwood MJ et al. Endothelial TRPC3 channel and associated NO release under hypoxia - reoxygenation[J/OL]FASEB J 201125(S1)∶820.6-820.6[2023-10-23]https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.25.1_supplement.820.6. DOI: 10.1096/fasebj.25.1_supplement.820.6 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Chu SF , Zhang Z , Zhou X et al. Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway[J]Acta Pharmacol Sin 201940(1)∶13-25. DOI: 10.1038/s41401-018-0154-z .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Wei Y , Gong J , Xu Z et al. Nrf2 promotes reparative angiogenesis through regulation of NADPH oxidase-2 in oxygen-induced retinopathy[J]Free Radic Biol Med 201699:234-243. DOI: 10.1016/j.freeradbiomed.2016.08.013 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
陈志敏,Email: mocdef.6ab21mzcyyky
B

张越:酝酿和设计实验、实施研究、采集数据、文章撰写;刘晓静、甄宇涵:实施动物实验研究;姚瑶、徐嫚鸿:实施细胞实验研究;邵斌:采集、分析动物实验数据;王艳辉:采集、分析细胞实验数据;刘志强、王伟:起草文章;毛爱玲、张宝月:统计学分析;张铭连、陈志敏:参与研究设计、对文章知识性内容的审阅及定稿

C
所有作者均声明不存在利益冲突
D
河北省重点研发计划项目中医药创新专项 (23377712D)
邢台市重点研发计划 (2022zz073)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号